Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers
- 1 February 2000
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 156 (2), 409-417
- https://doi.org/10.1016/s0002-9440(10)64744-x
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancerOncogene, 1998
- Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasiaZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosisCarcinogenesis: Integrative Cancer Research, 1995
- Molecular approaches to prevention and detection of epithelial ovarian cancerJournal of Cellular Biochemistry, 1995
- The epidemiology of ovarian cancerJournal of Cellular Biochemistry, 1995
- Apoptosis in bladder cancer as related to standard prognostic factors and prognosisThe Journal of Pathology, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA AneuploidyJapanese Journal of Cancer Research, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991